GSE164494 1 V 2 ANGIOTENSIN II MOUSE DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE164494 1 V 2 ANGIOTENSIN II MOUSE DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE164494 1 V 2 ANGIOTENSIN II MOUSE DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE164494 1 V 2 ANGIOTENSIN II MOUSE DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE164494 1 V 2 ANGIOTENSIN II MOUSE DN.

Results found

Linked to

 

Label

Description

 

Gene

coiled-coil domain containing 200

Gene

ETS repressor factor like

Gene

olfactory receptor family 14 subfamily J member 1

Gene

transmembrane protein 275

Gene

myosin XVB

Gene

olfactory receptor family 5 subfamily AU member 1

Gene

POU class 4 homeobox 2

Gene

olfactory receptor family 1 subfamily R member 1

Gene

cilia and flagella associated protein 45

Gene

Wnt family member 3A

  • Gene

    coiled-coil domain containing 200


  • Gene

    ETS repressor factor like


  • Gene

    olfactory receptor family 14 subfamily J member 1


  • Gene

    transmembrane protein 275



  • Gene

    olfactory receptor family 5 subfamily AU member 1


  • Gene

    POU class 4 homeobox 2


  • Gene

    olfactory receptor family 1 subfamily R member 1


  • Gene

    cilia and flagella associated protein 45


  • Gene

    Wnt family member 3A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.